Guggenheim Capital LLC trimmed its position in shares of Morgan Stanley (NYSE:MS) by 2.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,044,135 shares of the financial services provider’s stock after selling 28,300 shares during the quarter. Guggenheim Capital LLC owned approximately 0.06% of Morgan Stanley worth $54,785,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently modified their holdings of the business. Amundi Pioneer Asset Management Inc. boosted its stake in Morgan Stanley by 361.8% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 4,418,918 shares of the financial services provider’s stock valued at $231,860,000 after acquiring an additional 3,462,069 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Morgan Stanley by 18.3% in the third quarter. Dimensional Fund Advisors LP now owns 11,816,768 shares of the financial services provider’s stock worth $569,213,000 after purchasing an additional 1,828,697 shares during the period. Bank of New York Mellon Corp raised its holdings in Morgan Stanley by 14.2% in the fourth quarter. Bank of New York Mellon Corp now owns 12,643,249 shares of the financial services provider’s stock worth $663,392,000 after purchasing an additional 1,569,202 shares during the period. Bank of Montreal Can raised its holdings in Morgan Stanley by 37.7% in the fourth quarter. Bank of Montreal Can now owns 5,594,220 shares of the financial services provider’s stock worth $293,527,000 after purchasing an additional 1,532,991 shares during the period. Finally, DSAM Partners London Ltd raised its holdings in Morgan Stanley by 622.8% in the fourth quarter. DSAM Partners London Ltd now owns 791,331 shares of the financial services provider’s stock worth $41,521,000 after purchasing an additional 681,856 shares during the period. 86.06% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Daniel A. Simkowitz sold 87,050 shares of the company’s stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $53.55, for a total transaction of $4,661,527.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Jonathan Pruzan sold 52,204 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $55.35, for a total transaction of $2,889,491.40. The disclosure for this sale can be found here. Insiders sold a total of 239,254 shares of company stock valued at $13,085,019 over the last 90 days. Corporate insiders own 0.24% of the company’s stock.
Shares of Morgan Stanley stock opened at $57.11 on Thursday. The firm has a market cap of $102,977.40, a PE ratio of 15.79, a price-to-earnings-growth ratio of 0.99 and a beta of 1.50. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 2.75. Morgan Stanley has a 12 month low of $40.06 and a 12 month high of $59.38.
Morgan Stanley (NYSE:MS) last issued its earnings results on Thursday, January 18th. The financial services provider reported $0.84 EPS for the quarter, beating the consensus estimate of $0.77 by $0.07. The company had revenue of $9.50 billion during the quarter, compared to analysts’ expectations of $9.25 billion. Morgan Stanley had a net margin of 14.10% and a return on equity of 10.07%. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.81 EPS. equities analysts expect that Morgan Stanley will post 4.53 earnings per share for the current fiscal year.
MS has been the topic of several analyst reports. Keefe, Bruyette & Woods upgraded shares of Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $59.00 target price on the stock in a report on Tuesday, December 12th. Zacks Investment Research upgraded shares of Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 price objective on the stock in a report on Wednesday, January 3rd. Barclays raised their price objective on shares of Morgan Stanley from $52.00 to $62.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 2nd. Societe Generale downgraded shares of Morgan Stanley from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Finally, Vining Sparks reaffirmed a “buy” rating and issued a $60.00 target price on shares of Morgan Stanley in a research report on Monday, January 8th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. Morgan Stanley presently has a consensus rating of “Buy” and a consensus target price of $54.39.
TRADEMARK VIOLATION WARNING: This piece of content was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://ledgergazette.com/2018/03/22/morgan-stanley-ms-shares-sold-by-guggenheim-capital-llc.html.
Morgan Stanley Company Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.